Dermcare-Vet Company Profile

Background

Company Overview

Dermcare-Vet, established in 1981 by Professor Kenneth Mason, is a 100% Australian-owned and operated company specializing in veterinary dermatology. Professor Mason holds the distinction of being Australia's first registered specialist Veterinary Dermatologist. The company's mission is to develop and provide high-quality dermatological products tailored for specific veterinary purposes, thereby enhancing animal health and well-being. Dermcare-Vet's products are available in Australia, Asia, Africa, and the Pacific, supported by a growing network of distribution partners. Notably, their flagship product, Malaseb™, is manufactured and distributed under license in both North and South America, as well as in Europe.

Key Strategic Focus

Core Objectives and Specialization

Dermcare-Vet concentrates on a limited range of high-quality products developed for specific veterinary dermatological purposes. The company's strategic focus includes:

• Research and Development: Conducting in-house research and collaborating with institutions like the University of Queensland and Griffith University to investigate causes and treatments of rare or poorly understood animal diseases, particularly in the field of allergies.

• Product Quality: Ensuring all products meet stringent quality standards to effectively address various skin conditions in animals.

• Global Distribution: Expanding the availability of their products through a network of international distributors, thereby reaching a broader market.

Financials and Funding

Revenue and Employee Information

As of the latest available data, Dermcare-Vet reports an annual revenue of approximately $2.6 million and employs around 27 staff members.

Pipeline Development

Product Portfolio

Dermcare-Vet offers a range of products designed to treat various dermatological conditions in animals. Key products include:

• Malaseb® Medicated Shampoo: Indicated for the treatment of seborrheic dermatitis and as an aid in treating dermatophyte (ringworm) infections in dogs and cats.

• Aloveen® Oatmeal Shampoo and Conditioner: Soothing oatmeal-based products for dogs and cats, now available in larger 5-liter pump packs.

• Pyohex® Medicated Shampoo and Conditioner: Antibacterial products for superficial bacterial dermatitis in dogs.

• Otoflush®: A neutral, buffered, antimicrobial ear flush for dogs.

• Permoxin: An insecticidal spray and rinse for dogs and horses.

• Barazone®: A prescription leave-on conditioner for the symptomatic treatment of canine atopic dermatitis, contact allergy, and other pruritic conditions in dogs.

Technological Platform and Innovation

Proprietary Technologies and Scientific Methodologies

Dermcare-Vet's commitment to innovation is evident through:

• In-House Research and Development: Focusing on creating products that address specific veterinary dermatological needs.

• Collaborative Research: Partnering with academic institutions to advance understanding and treatment of animal skin conditions.

• Product Efficacy: Developing formulations with proven effectiveness for various skin conditions in animals.

Leadership Team

Key Executives

While specific details about the current leadership team are not publicly disclosed, the company's foundation by Professor Kenneth Mason underscores its strong roots in veterinary dermatology expertise.

Competitor Profile

Market Insights and Dynamics

The global veterinary dermatology market is experiencing significant growth, driven by increasing pet ownership and heightened awareness of animal health. The market is projected to reach USD 30.31 billion by 2030, growing at a CAGR of 8.5% from 2025.

Competitor Analysis

Dermcare-Vet operates in a competitive landscape alongside key players such as:

• Elanco Animal Health Incorporated: Offers a range of veterinary products, including dermatological treatments.

• Merck & Co., Inc.: Provides veterinary pharmaceuticals with a focus on dermatology.

• Virbac: Specializes in animal health products, including dermatology solutions.

• Zoetis Inc.: A leading animal health company with a comprehensive dermatology portfolio.

• Boehringer Ingelheim International GmbH: Offers innovative treatments for animal skin conditions.

Strategic Collaborations and Partnerships

Distribution Partnerships

Dermcare-Vet has established a robust network of international distributors to enhance its global reach. Notable partners include:

• GLA Pharma: Serving New Zealand.

• Chemfit Fine Chemicals South Africa: Covering multiple African countries.

• Eurovets Veterinary Medicines L.L.C: Operating in the UAE, Kuwait, Qatar, Saudi Arabia, Oman, and Bahrain.

• Interpharma Public Company Limited: Serving Myanmar, Thailand, Vietnam, Cambodia, and Laos.

• PT Bevos Prima Center: Operating in Indonesia.

• E-Rei International: Serving Taiwan.

• Alfamedic Ltd/Dr Vos Vet Consult Ltd: Operating in Hong Kong.

• Guangzhou Lifu Trading Ltd: Serving China.

• Dechra Veterinary Products: Covering South Korea, various European countries, the United States, and Canada.

• Lee Guan Chuan and Age D’Or: Operating in Singapore.

• Pet Arcade Sdn. Bhd.: Operating in Malaysia.